Gilead Sciences' R&D program developed 28 medicines that enable the treatment of health conditions
Data points
Enlarge the tiles to compare the data point.
5,000Mn
usd
capital invested in R&D
Complete | Disclosed
2022
18.50
%
% of the total sales
Complete | Disclosed
2022
500,000
individuals
number of people's health positively impacted
Partial | Disclosed
2022
Sources
Share this Analysis
Keen to rectify an issue with this analysis?
Report issue